Critical minerals have drawn steady attention from traders as Western governments work to reduce reliance on Chinese supply chains. This comparison looks at two Nasdaq-listed names in the space: ALOY, or REalloys Inc., which is building a North American rare earth-to-magnet platform, and NB, or NioCorp Developments Ltd., which is advancing the Elk Creek niobium, scandium, and titanium project in Nebraska. Both remain early-stage and capital-intensive, with limited or no commercial revenue, so their relative positioning offers a useful lens on risk, balance-sheet strength, and catalyst timing in this segment.
REalloys Inc. (ALOY) began trading on the Nasdaq Capital Market in February 2026 after a reverse recapitalization with Blackboxstocks. The company is putting together a vertically integrated supply chain for rare earth elements and high-performance neodymium-iron-boron magnets, covering the Hoidas Lake project in Saskatchewan, a midstream separation partnership with the Saskatchewan Research Council, and the PMT Critical Metals metallization facility in Euclid, Ohio. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Market activity for ALOY has shown high volatility, with a beta near 1.44 and the share price well below its 52-week high of roughly $26.90. The company has recorded only modest revenue while posting sizable net losses, driven largely by stock-based compensation. A $100 million private placement and a $46.8 million public offering have supported liquidity, and management has indicated that funding is in place for near-term projects. Analysts maintain a Buy rating with price targets above current levels, based on expectations around facility commissioning and defense-related demand.
NioCorp Developments Ltd. (NB) is focused on the Elk Creek Critical Minerals Project, targeting niobium, scandium, titanium, and rare earth elements. The company is still pre-commercial and has not yet recorded meaningful product revenue, so its case rests on project financing, construction progress, and eventual output.
Recent weeks have been difficult for the stock, which trades near the low end of a 52-week range of approximately $2.39 to $8.18 and is down more than 50% year to date. NB carries a low beta of about 0.24 and holds a substantial cash position that, by some measures, exceeds its market capitalization, resulting in a negative enterprise value. Recent developments include the U.S. Export-Import Bank reaffirming a target to finance roughly 65% of upfront capital expenditures and a definitive offtake agreement covering 100% of planned production. The company also reported a modestly positive quarterly net income figure, though operating losses continue.
The two companies differ on several fronts even though they operate in adjacent critical minerals markets. ALOY sits further along the commercialization path, already producing rare earth metals and magnets from an operating facility and posting gross margins above 50% in recent quarters. NB, on the other hand, has no commercial revenue and must complete a major construction project before sales can begin.
Risk profiles vary as well. ALOY shows higher volatility (beta near 1.44) and greater dependence on equity financing and stock-based compensation, which has contributed to reported losses. NB appears more defensive on balance-sheet metrics, with minimal debt, a low beta near 0.24, and government-supported financing routes. That said, NB has seen meaningful share dilution, with shares outstanding rising more than 100% over the past year. Catalysts for ALOY center on facility commissioning and defense procurement, while those for NB focus on EXIM financing milestones and offtake certainty.
After weighing trend consistency, stability, catalysts, and relative positioning, the assessment favors NB in the current environment. The preference is driven less by momentum—where NB remains in a downtrend—and more by structural factors: a cash position exceeding market capitalization, a negative enterprise value, materially lower volatility, and financing and offtake developments that reduce some execution uncertainty. ALOY offers a more advanced operational footprint and higher gross margins, but its elevated beta and reliance on equity issuance introduce comparatively more near-term risk. This view is probabilistic and based on current observable conditions rather than a firm prediction.
When evaluating names like these, I often turn to Tickeron’s AI Trading Bots to test how different automated strategies might respond to the same market conditions. The platform offers a range of bots with varying styles, timeframes, and performance data, which can provide an extra layer of perspective on positioning without replacing core fundamental review.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
NB saw its Momentum Indicator move below the 0 level on November 10, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 97 similar instances where the indicator turned negative. In 89 of the 97 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for NB turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 35 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for NB entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NB's RSI Oscillator exited the oversold zone, 22 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +20.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where NB advanced for three days, in 197 of 241 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.981) is normal, around the industry mean (6.813). P/E Ratio (-7.073) is within average values for comparable stocks, (-0.701). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.026). Dividend Yield (0.000) settles around the average of (0.016) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (283.864).
The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. NB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry OtherMetalsMinerals